US stocks jumped on Thursday as investors weighed fresh inflation and labor data against high-running expectations for a ...

Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of ...

Moderna Inc. (NASDAQ: MRNA) saw its stock plunge more than 14% on Thursday, following the company’s announcement of ...

CSL and self-amplifying mRNA (sa-mRNA) pioneer Arcturus Therapeutics today announced ... Vaccines Innovation Unit, CSL. "Today's approval further demonstrates CSL's promise to pursue, develop, and ...

Moderna uses the same mRNA technology in its highly safe and effective coronavirus vaccine. In the study, six macaques were vaccinated with the mRNA vaccine, and another six received an equivalent ...

Now, a new vaccine candidate from Moderna, mRNA-1769, has been shown to more effectively limit symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against Jim Cramer’s other must-watch stocks. In a recent episode of Mad Money, Jim Cramer traveled to ...

A recent study published in Cell shows that Moderna's experimental mRNA vaccine for mpox is more effective than existing vaccines at reducing symptoms and disease duration. Tested on macaques ...

Using mRNA technology similar to Covid-19 vaccines, BNT116 aims to enable the immune system to target NSCLC tumour markers, attacking cancer cells while sparing healthy ones. Lung cancer is the ...

Moderna (NASDAQ:MRNA) is planning to launch a messenger-RNA-based vaccine for skin cancer as early as next year, Japanese business publication Nikkei reported on Thursday, citing an interview with ...